About Rejuvatek Medical
Rejuvatek Medical is a private company based in Sandy, Utah. It has reported $950,000 raised in three offerings on Form D since July 2019.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 10, 2026 | Mar 23, 2026 | $500,000of $3.0M target | 1 | $500K | EquityRule 506(b) | Form D ↗ |
| Aug 29, 2020 | Sep 10, 2020 | $150,000of $1.0M target | 3 | $50,000 | EquityRule 506(b) | Form D ↗ |
| Jun 27, 2019 | Jul 11, 2019 | $300,000of $2.5M target | 1 | $300K | Equity, OptionsRule 506(b) | Form D ↗ |
| Total, three offerings | $950,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Rejuvatek Medical's Form D filed Mar 23, 2026.
JS
Earlier filings also listed William Kelley (director, last listed Sep 2020), Kerry Assil (director, last listed Sep 2020), Bradley Bertoch (director, last listed Sep 2020) and William Kelly (director, last listed Jul 2019).